Complete genomic reprogramming happens twice during the life of a genome, once during the formation of gametes in their parents and once after their union at fertilization. For that matter complete genomic reprogramming happens twice in the same parental cell, the oocyte, when it is forming and after it matures and receives the paternal gamete. Control of these processes in this unique single cell is epigenetic, and our understanding of it is based on information gleaned from imprinting, X chromosome inactivation, and activation and silencing of endogenous retroviruses (ERV). Activation of ERVs is attributed to demethylation of chromatin and DNA, whereas silencing requires methylation, attributed to the nuage proteins, which engage the Piwi-interacting RNA pathway and other posttranscriptional mechanisms. This reprogramming process has evolved throughout speciation because in mammals, but not fish, flies and worms, nuage-component muations affect male and female gameotgenesis differentially. Transcription of ERVs is derepressed in both sexes in nuage-mutant mice, but whereas males are sterile, females are fertile. Using a proteomic approach we now report molecular interactions between nuage proteins and components of the oocyte cytoplasmic lattice and speculate how this interaction could preserve ERV/host chimeric gene products affecting female fertility.
A glimmer of the idea behind this work was initiated by a team working in the laboratory of Hilary Koprowski. They found endogenous intracisternal A-type retrovirus particles (IAP) in the cytoplasm of oocytes and preimplantation mouse embryos [1] [2] [3] , which were packed with the cytoplasmic lattices (CPLs) characteristic of these developmental stages [4] .
The epigenome is reprogrammed twice in the life of a genome, during gametogenesis and on fertilization, when histone methylation and the transcription-repressive DNA methylation genomic marks are erased and then reestablished. Demethylation of the genome in those cells designated to become the primordial germ cell starts soon after they are specified and completes as these migratory cells colonize the gonads. Once in the gonad, remethylation of the germ cell genome initiates and proceeds in a sex-specific fashion until the mature, differentiated male and female gametes are formed. On fertilization, the gametic genomes are immediately reprogrammed, demethylated in the zygote and remethylated in the early embryo to form the mature pluripotent diploid genome. During this period of global demethylation of the germ cell genome, the methyl marks in regions of the parentally imprinted genes are also demethylated to be reestablished in the gametes, in males by birth and in females during oogenesis (see [5] for review). After fertilization, preservation of the site-and sex-specific methyl marks on imprinted genes is protected by members of the Tripartite motif-containing 28 (TRIM28) complex [5] .
These 2 periods of genome demethylation are windows of opportunity for transposition of endogenous retroviruses (ERVs), with their potential for genome disruption. Although most ERVs are assumed to be remethylated and repressed, transcripts from some, such as the highly defective mouse retrovirus, Mouse Transcript (MT), are highly abundant in full-grown oocytes. Chimeric transcripts, between mouse transcript and other long terminal repeats (LTRs) and host genes are also expressed in the oocyte and preimplantationstage embryo, leading to the speculation that some of these chimeric transcripts serve a specific function during the oocyte to embryo transition [6] . Control of some ERVs and their chimeric transcripts may result from the preservation of methyl marks on previously silenced components by the TRIM28 complex or by interaction with molecules of the nuage, which also regulate the production of Piwi-interacting RNAs (piRNAs) [7, 8] .
METHODS
C57BL/6J mice, initially from The Jackson Laboratory were housed and bred in the Central Animal Laboratory of the Institute of Medical Biology, Agency for Science Technology and Research (A*STAR), Singapore. Experiments were approved by the Animal Experimental Committee and conducted in accordance with institutional and national guidelines (Institute permit 10 300). Ovaries were obtained from 5-day-old mice, as described elsewhere [9] . Approximately 200 ovaries were used per experiment. Mouse Vasa Homolog (Mvh)-mutant mice were back-crossed to C57BL/6J ≥6 times before use [9] .
Peptidyl Arginine Deiminase Type IV (Padi6) antibody was kindly provided by Scott Coonrod (Cornell University), and MVH antibody (catalogue #13 840) was purchased from Abcam. In vivo coimmunoprecipitation, Western blotting and immunofluorescent assays on fixed, sectioned ovaries were performed as described elsewhere [9] . The mouse vasa homologue (Mvh) was cloned into a a cytomegalovirus (CMV) promoterdriven plasmid containing a human influenza virus hemagglutinin (HA) tag ( pCMV-HA) and the mouse Padi6, or Nlrp5, or Filia genes were cloned into a CMV promoter-driven plasmid containing a myelocytomatosis ( described elsewhere [9] , using primers Tle6F (CAGTGACA CCTTTGGTGGAA), Tle6R (TTCACGATGGACAAATACCG), Padi6F (TTTCTCACCGGCATCGAG), Padi6R, (TTGGCA TGTCCAGTTGTCC
RESULTS AND DISCUSSION
To explore the control of ERVs during the reprogramming processes in female mice, we investigated the role of the nuage components, proteins that regulate the piRNA pathway and prevent rampant expression of ERVs, and chimeric LTR/host genes in oocytes and early embryos. In mouse testes, repression of ERV expression by the nuage proteins, MVH and Piwi-like 2 (PIWIL2/MILI), correlates with de novo DNA methylation of IAPs and LINE LTRs and with male sterility [10] [11] [12] . It is less clear how the piRNA pathway regulates ERV and chimeric transcript genes in mouse oocytes. As in males, ERV and chimeric transcripts are significantly up-regulated in primordial follicles of Mvh-, Mili-, and GasZ-null mutant mice, although female fertility is unaffected in mice [9] , in sharp contrast to results from null mutants of nuage genes in flies, fish, and frogs, where nuage mutations lead to meiotic arrest of both male and female germ cells [13, 14] .
To determine whether the nuage components have a role in posttranscriptional control of retrotransposons and LTR/host In primordial follicles, the nuage forms an messenger ribonucleoprotein particle (mRNP) mRNP silencing complex/subcomplex that sequesters chimeric transcripts, such as the Mouse Transcript A (MTA/Dnajc11) (Piwi-interacting RNAs [ piRNAs] target the MTA on Dnajc11 [9] ). The nuage proteins also bind components of the CPLs, impeding their localization to the subcortical region. In the mature oocyte, as the nuage components diminish, the components reassemble in the SCMC and the chimeric transcripts can be translated. Red and green circles represent CPL and nuage components respectively. Abbreviation: mRNA, messenger RNA. chimeric transcripts in the female gamete, we performed mass spectrometric analyses of protein complexes pulled down from lysates of postnatal day 5 primordial ovarian follicles along with the nuage protein, MVH, a marker of the primordial germ cell [15] (data not shown). From this preliminary experiment we obtained evidence that MVH associated with many proteins, including PADI6 and NLRP5, members of the subcortical maternal complex (SCMC) of the oocyte [16] . Besides being components of the SCMC, PADI6 and NLRP5 are also localized to and required for the formation of the CPL [17, 18] , an abundant oocyte and early embryo-restricted, keratin-containing, fibrillar matrix found at early stages of oocyte growth (30-40 µm) [4] , which persists to the blastocyst stage [19] . Padi6 −/− female mice are infertile, and their maternal-null oocytes arrest at the 2-cell stage, which is attributed to the failure to citrunillate histone H4 [20] and to store the ribosomal components necessary for protein translation during the transition from oocyte to embryo [17] .
To test the veracity of our mass spectrometric findings, we performed pull-down assays on postnatal day 5 mouse ovary lysates and demonstrated that PADI6 coimmunoprecipitated with MVH ( Figure 1A ). In vitro coimmunoprecipitation experiments not only confirmed the interaction between HA-tagged MVH with PADI6 but also demonstrated that 2 more components of the CPL, NLRP5 and FILIA, an RNA-binding protein, interact with HA-tagged MVH ( Figure 1B) . Immunolocalization studies showed that PADI16 and MVH overlap strongly in the primordial oocyte cytoplasm (presumably in the CPL) of paraformaldehyde-fixed sections of postnatal day 5 ovaries (Figure 1C ), indicating that PADI6 is spatially restricted by the presence of the nuage component MVH.
To find out whether MVH had any effect on the expression of CPL components Padi6 and Tle6, or on the chimeric gene, MTA/Spin1 [6] , we compared transcript levels in postnatal day 5 primordial ovarian follicles from Mvh-null mutant and normal mice. Intriguingly, we found all 3 transcripts to be up-regulated in the null mutant (Figure 2 ). This observation suggests that expression of MVH may regulate either the transcription of these genes or, more likely, the stability of their transcripts in the cytoplasm. It was reported elsewhere that piRNA-dependent mRNA degradation affects posttranscriptional control of retrotransposons in Drosophila germline cells [13] . We now propose that a similar mechanism acts in mouse primoridal follicles. That is, in the absence of MVH, one would find an increase of nuage-targeted RNAs because their degradation has been disrupted.
We suggest that the nuage component, MVH, and the CPL proteins form an messenger ribonucleoprotein particle (piRNA)-silencing complex in the primordial follicles, which serves 2 purposes: regulation of the retrotransposons themselves and sequestration of vital maternal chimeric transcripts (eg, MTA/Dnajc11 or MTA/Spin1) from the ribosomes so they cannot be translated until required. In the latter case, when nuage expression ceases and MVH abundance decreases during oocyte maturation, the complex dissociates and the CPL proteins relocate to the subcortical region where their associated RNAs can be translated (Figure 3 ). In fact, PADI6 must localize to the SCMC for embryonic genome activation and protein translation in the early embryo [21] . We hypothesize that piRNA-dependent silencing of vital chimeric maternal transcripts by the nuage is a posttranscriptional event requiring sequestration of transcripts to prevent their premature, yet necessary, translation. This study represents an attempt to unravel the complex spatiotemporal interactions and multiple molecular mechanisms necessary to establish the primary and prime reprogramming milieu of the oocyte.
